Literature DB >> 14638399

Role of hepatitis B virus specific cytotoxic T cells in liver damage and viral control.

A Bertoletti1, M Maini, Roger Williams.   

Abstract

To understand the role of cytotoxic T cells in liver damage and viral control, we used human histocompatibility leukocyte antigen (HLA)-peptide tetramers that allow direct ex vivo quantification of circulating and liver-infiltrating HBV-specific CD8 cells. Studies were carried out in two groups of patients, one without liver inflammation and minimal HBV replication and the other with liver damage and inflammation along with a high level of viral replication. Contrary to expectation, a high frequency of intrahepatic HBV-specific CD8 cells was found in the former group, i.e., the absence of hepatic immunopathology. In the replicating viraemic group, the virus specific T cells were diluted among the liver infiltrates; although with the massive cellular infiltration that was present, the absolute number was similar. It was also shown that in the low viraemia group the reservoir of CD8+ cells present in the circulation was able to expand after specific virus recognition and that this was not detectable in highly viraemic patients with liver inflammation. These results show that inhibition of virus replication can be independent of liver damage and when the HBV-specific CD8 response is unable to control virus replication it may contribute to liver pathology not only directly but by causing recruitment of non-virus specific T cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14638399     DOI: 10.1016/j.antiviral.2003.08.012

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  28 in total

1.  Antiviral treatment with alpha interferon up-regulates CD14 on liver macrophages and its soluble form in patients with chronic hepatitis B.

Authors:  Patrizia Carotenuto; Debby van Riel; André Artsen; Sven Bruijns; Fons G Uytdehaag; Jon D Laman; Andeltje B van Nunen; Pieter E Zondervan; Robert A De Man; Albert D Osterhaus; Oscar Pontesilli
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

2.  Coimmunization with IL-15 plasmid enhances the longevity of CD8 T cells induced by DNA encoding hepatitis B virus core antigen.

Authors:  Wei Zhang; Sheng-Fu Dong; Shu-Hui Sun; Yuan Wang; Guang-Di Li; Di Qu
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

Review 3.  Immune therapy for hepatitis B.

Authors:  Sheikh Mohammad Fazle Akbar; Mamun Al-Mahtab; Md Sakilur Islam Khan; Ruksana Raihan; Ananta Shrestha
Journal:  Ann Transl Med       Date:  2016-09

Review 4.  The role of the liver in sepsis.

Authors:  Jun Yan; Song Li; Shulin Li
Journal:  Int Rev Immunol       Date:  2014-03-10       Impact factor: 5.311

5.  Flares in chronic hepatitis B patients induced by the host or the virus? Relation to treatment response during Peg-interferon {alpha}-2b therapy.

Authors:  H J Flink; D Sprengers; B E Hansen; M van Zonneveld; R A de Man; S W Schalm; H L A Janssen
Journal:  Gut       Date:  2005-05-29       Impact factor: 23.059

6.  Associations between cytotoxic T lymphocyte-associated antigen-4 polymorphisms and serum tumor necrosis factor-α and interferon-γ levels in patients with chronic hepatitis B virus infection.

Authors:  Qunying Han; Shaoqiong Duan; Guoyu Zhang; Zhu Li; Na Li; Qianqian Zhu; Yi Lv; Jinghong Chen; Zhengwen Liu
Journal:  Inflamm Res       Date:  2011-08-17       Impact factor: 4.575

7.  IFN-gamma increases efficiency of DNA vaccine in protecting ducks against infection.

Authors:  Jian-Er Long; Li-Na Huang; Zhi-Qiang Qin; Wen-Yi Wang; Di Qu
Journal:  World J Gastroenterol       Date:  2005-08-28       Impact factor: 5.742

8.  Serum cytokine profile in patients with hepatitis B e antigen-negative chronic active hepatitis B and inactive hepatitis B virus carriers.

Authors:  Dimitra Dimitropoulou; Marina Karakantza; Georgios L Theodorou; Lydia Leonidou; Stelios F Assimakopoulos; Athanasia Mouzaki; Charalambos A Gogos
Journal:  World J Gastrointest Pathophysiol       Date:  2013-02-15

9.  Frequencies and characterization of HBV-specific cytotoxic T lymphocytes in self-limited and chronic hepatitis B viral infection in China.

Authors:  Xinxing Yang; Youhua Hao; Zhi Liu; Ling Chen; Honghui Ding; Xiping Zhao; Mengji Lu; Dongliang Yang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-10-11

10.  Rational design of a multiepitope vaccine encoding T-lymphocyte epitopes for treatment of chronic hepatitis B virus infections.

Authors:  Erik Depla; Annegret Van der Aa; Brian D Livingston; Claire Crimi; Koen Allosery; Veronique De Brabandere; Jonathan Krakover; Sidharta Murthy; Manley Huang; Scott Power; Lilia Babé; Carol Dahlberg; Denise McKinney; Alessandro Sette; Scott Southwood; Ramilla Philip; Mark J Newman; Lydie Meheus
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.